Discontinued — last reported Q4 '20
HCA Healthcare Available-for-Sale Debt Securities - Amortized Cost increased by 38.5% to $18.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 47.1%, from $34.00M to $18.00M.
An increase reflects new debt security purchases, while a decrease indicates maturities or sales of existing holdings.
This represents the original cost of debt securities classified as available-for-sale, adjusted for amortization of prem...
Standard accounting metric; allows for comparison of investment cost bases across financial institutions.
afs_debt_securities_amortized_cost| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $8.00M | $20.00M | $26.00M | $30.00M | $23.00M | $13.00M | $14.00M | $29.00M | $34.00M | $24.00M | $13.00M | $18.00M |
| QoQ Change | — | — | — | +150.0% | +30.0% | +15.4% | -23.3% | -43.5% | +7.7% | +107.1% | +17.2% | -29.4% | -45.8% | +38.5% |
| YoY Change | — | — | — | — | — | +275.0% | +15.0% | -50.0% | -53.3% | +26.1% | +161.5% | +71.4% | -55.2% | -47.1% |